☆ 4.7 Article

CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel

BLOOD (2021)

Get Full Text
Add to Collection

Journal

BLOOD
Volume 138, Issue 12, Pages 1081-1085

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2021010930

Keywords

-

Categories

Hematology

Funding

  1. Kite, a Gilead Company
  2. University of Texas MD Anderson Cancer Center B-cell Lymphoma Moonshot
  3. National Institutes of Health, National Cancer Institute Cancer Center Support Grant [P30 CA016672]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.